Is it safe and efficient to use nonsteroidal anti-inflammatory agent by selective reduction of prostaglandin production?
Kankaanranta, H.; Vapaatalo, H.
Duodecim; Laaketieteellinen Aikakauskirja 112(5): 419-424
1996
ISSN/ISBN: 0012-7183 PMID: 10592604 Document Number: 460705
Document emailed within 1 workday
Related Documents
Krausz, F.; Breliere, J.C.; Vaillant, J.; Brunaud, M.; Navarro, J. 1974: A new nonsteroidal anti-inflammatory agent: bucloxic acid (804 CB) Arzneimittel-Forschung 24(9a Suppl): 1364-1367Patrignani, P.; Panara, M.R.; Sciulli, M.G.; Santini, G.; Renda, G.; Patrono, C. 1997: Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 48(4): 623-631
Sherer, Y.; Bar-Dayan, Y.; Shoenfeld, Y. 1997: Selective inhibitors of cyclooxygenase-2 in upgrade in nonsteroidal anti-inflammatory drugs Harefuah 132(6): 411-416
Mascagni, P.; Sabbatini, V.; Biordi, L.; Martinotti, S.; Allegretti, M.; Marullo, A.; Caselli, G.; Bertini, R. 2000: R- and S-isomers of nonsteroidal anti-inflammatory drugs differentially regulate cytokine production European Cytokine Network 11(2): 185-192
Karateev, A.E. 2014: Selective cyclooxygenase-2 inhibitors and protected nonsteroidal anti-inflammatory agents: two methods for the prevention of iatrogenic complications Klinicheskaia Meditsina 92(8): 54-61
Takeuchi, K.; Suzuki, K.; Yamamoto, H.; Araki, H.; Mizoguchi, H.; Ukawa, H. 1998: Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 49(4): 501-513
Busch, J.; Hammer, M.; Brunkhorst, R.; Wagener, P. 1988: Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability Zeitschrift für Rheumatologie 47(3): 156-160
Busch, J.; Hammer, M.; Brunkhorst, R.; Wagener, P. 1988: Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability Zeitschrift für Rheumatologie 47(3): 156-160
Galeazzi, M.; Marcolongo, R. 1993: A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases Drugs under Experimental and Clinical Research 19(3): 107-115
Tompkins, R.B. 1979: Nonsteroidal anti-inflammatory drugs Minnesota Medicine 62(9): 677-678
Snyder, E.G. 1976: Nonsteroidal anti-inflammatory drugs American Family Physician 14(6): 29
Zarro, V. 1984: Nonsteroidal anti-inflammatory drugs: a review American Family Physician 30(5): 243-246
Baisac, J.; Henrich, W.L. 1994: Nephrotoxicity of nonsteroidal anti-inflammatory drugs Mineral and Electrolyte Metabolism 20(4): 187-192
Ridolfo, A.S. 1978: Nonsteroidal anti-inflammatory agents in arthritis American Family Physician 17(2): 131-138
Shapira, S.C.; Magora, F. 1993: The use of nonsteroidal anti-inflammatory drugs for premedication Harefuah 124(9): 594-595
Nicholls, D. 1987: Pseudoporphyria from nonsteroidal anti-inflammatory drugs New Zealand Medical Journal 100(827): 427-428
Hagler, L. 1984: Nephrotoxicity of nonsteroidal anti-inflammatory drugs American Family Physician 30(5): 27-30
Karateev, A.E. 2014: Meloxicam: the golden mean of nonsteroidal anti-inflammatory drugs Terapevticheskii Arkhiv 86(5): 99-105
Köhler, L.; Zeidler, H.; Merkesdal, S.; Kuipers, J.G. 2000: Safety of celecoxib vs other nonsteroidal anti-inflammatory drugs JAMA 284(24): 3123; Author Reply 3124
Krajcík, S.; Salamonová, H.; Cápová, L. 1995: Treatment with nonsteroidal anti-inflammatory agents in the aged Vnitrni Lekarstvi 41(7): 488-492